The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1434-9949
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study ; volume:41 ; number:12 ; day:12 ; month:8 ; year:2022 ; pages:3747-3752 ; date:12.2022
Clinical rheumatology ; 41, Heft 12 (12.8.2022), 3747-3752, 12.2022
- Creator
-
Swart, I. A. P.
Visman, I. M.
Heslinga, M.
Horst-Bruinsma, I. E. van der
Denderen, J. C. van
Nurmohamed, M. T.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10067-022-06330-9
- URN
-
urn:nbn:de:101:1-2023012522580086432482
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Swart, I. A. P.
- Visman, I. M.
- Heslinga, M.
- Horst-Bruinsma, I. E. van der
- Denderen, J. C. van
- Nurmohamed, M. T.
- SpringerLink (Online service)
Other Objects (12)
Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
Monitoring of anti-TNF biological treatments
Andersson lesion in ankylosing spondylitis
Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis
Stopping Anti-TNF in CD Remitters: Cons
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study
Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
Monitoring of anti-TNF biological treatments
Andersson lesion in ankylosing spondylitis
Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis
Stopping Anti-TNF in CD Remitters: Cons
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study
Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
Monitoring of anti-TNF biological treatments
Andersson lesion in ankylosing spondylitis
Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis
Stopping Anti-TNF in CD Remitters: Cons
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)